NASDAQ$NNOX
Nano-X Imaging Ltd. · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Briefing
Nanox reported Q4 2024 results with a modest revenue increase but continued operating losses.
Nanox generated $3.0 million in revenue for Q4 2024, up from $2.4 million in the prior year period. Despite revenue growth, the company posted a net loss of $14.1 million and an operating loss of $15.0 million. The non-GAAP EPS stood at -$0.17. Teleradiology services accounted for most of the revenue.
- Generated $3.0 million in Q4 revenue, up from $2.4 million YoY.
- Posted a net loss of $14.1 million and an operating loss of $15.0 million.
- Teleradiology services contributed $2.8 million in revenue with improved gross margins.
- Cash and cash equivalents totaled $39.3 million as of December 31, 2024.
Headline financials
Revenue & EPS history
Nano-X · Revenue · Quarterly
$3M
Revenue by segment
Nano-X · $3.65M total across 3 segments · Q4 2025
- Teleradiology services$3.1M—85.0%
- AI and software solutions$500K—13.7%
- Imaging systems and OEM$49K—1.3%
Forward guidance
Nanox plans to build on its regulatory milestones and expand commercialization in the US and EU, with particular emphasis on its ARC system and AI product line.
Tailwinds
- FDA clearance of Nanox.ARC for general use achieved in December 2024.
- CE mark received in EU for Nanox.ARC in February 2025.
- New partnerships with distributors in Romania and Greece to support EU expansion.
- Signed two new AI customers in Q1 2025, including Ezra AI.
- Entered 2025 with a growing portfolio of technologies poised for commercialization.
Headwinds
- Continued operating and net losses.
- Gross margins remain negative on a GAAP basis.
- Revenue from imaging systems and AI remains minimal.
- Legal and administrative expenses increased significantly.
- High cash burn rate from operating activities ($36.6M in Q4).
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 17 quarterly earnings reports · overlaid with Q4 2024
+2.0%
Avg return
Earnings day
-0.7%
Avg return
5 days after
-6.4%
Avg return
30 days after
50%
9 / 18 earnings
Positive
+17.7%
Q3 2022
Best reaction
-7.0%
Q4 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.5% | -5.1% | — | |
| Q4 2025 | -0.5% | -39.1% | -36.5% | |
| Q2 2025 | -5.3% | -6.2% | -15.7% | |
| Q1 2025 | -0.2% | -1.1% | -4.8% | |
| Q4 2024 | -4.4% | -15.9% | -3.8% | |
| Q3 2024 | +8.0% | +3.1% | +14.8% | |
| Q2 2024 | +5.7% | -2.8% | -12.6% | |
| Q4 2023 | +1.5% | +8.1% | -6.2% | |
| Q3 2023 | +7.1% | +9.0% | +5.1% | |
| Q2 2023 | -3.7% | -7.5% | -22.8% | |
| Q1 2023 | +2.9% | -2.1% | -1.6% | |
| Q4 2022 | -5.5% | -1.7% | -16.7% | |
| Q3 2022 | +17.7% | +22.4% | -19.4% | |
| Q2 2022 | -0.8% | -7.0% | -18.6% | |
| Q1 2022 | +8.1% | -2.8% | +9.0% | |
| Q4 2021 | +14.1% | +42.1% | -2.4% | |
| Q4 2020 | -7.0% | -12.1% | -7.8% | |
| Q3 2020 | +0.2% | +5.9% | +30.6% | |
| Q1 2020 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro